{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T08:29:15Z","timestamp":1740126555292,"version":"3.37.3"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"45","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,12,1]]},"DOI":"10.1093\/eurheartj\/ehab819","type":"journal-article","created":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T17:52:51Z","timestamp":1638381171000},"page":"4607-4611","source":"Crossref","is-referenced-by-count":1,"title":["Percutaneous coronary interventions: more complex than fixing stenoses"],"prefix":"10.1093","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9482-411X","authenticated-orcid":false,"given":"Filippo","family":"Crea","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy"},{"name":"Department of Cardiovascular and Pulmonary Sciences, Catholic University of the Sacred Heart, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,12,1]]},"reference":[{"key":"2021120112085353200_ehab819-B1","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1093\/eurheartj\/ehaa824","article-title":"Evolution of antithrombotic therapy in patients undergoing percutaneous coronary intervention: a 40-year journey","volume":"42","author":"Cao","year":"2021","journal-title":"Eur Heart J"},{"key":"2021120112085353200_ehab819-B2","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/eurheartj\/ehy394","article-title":"2018 ESC\/EACTS Guidelines on myocardial revascularization","volume":"40","author":"Neumann","year":"2019","journal-title":"Eur Heart J"},{"key":"2021120112085353200_ehab819-B3","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehab533","article-title":"Ticagrelor monotherapy in patients with chronic kidney disease undergoing percutaneous coronary intervention: TWILIGHT-CKD","volume":"42","author":"Stefanini","year":"2021","journal-title":"Eur Heart J"},{"key":"2021120112085353200_ehab819-B4","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1093\/eurheartj\/ehab037","article-title":"Ticagrelor monotherapy following percutaneous coronary intervention for acute coronary syndrome in TWILIGHT patients: still a future for aspirin?","volume":"42","author":"Lunardi","year":"2021","journal-title":"Eur Heart J"},{"key":"2021120112085353200_ehab819-B5","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1093\/eurheartj\/ehaa670","article-title":"Ticagrelor alone vs. ticagrelor plus aspirin following percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes: TWILIGHT-ACS","volume":"41","author":"Baber","year":"2020","journal-title":"Eur Heart J"},{"key":"2021120112085353200_ehab819-B6","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehab702","article-title":"Ticagrelor monotherapy in patients at high bleeding risk undergoing percutaneous coronary intervention: TWILIGHT-HBR","volume":"42","author":"Escaned","year":"2021","journal-title":"Eur Heart J"},{"key":"2021120112085353200_ehab819-B7","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1093\/eurheartj\/ehz372","article-title":"Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding Risk","volume":"40","author":"Urban","year":"2019","journal-title":"Eur Heart J"},{"key":"2021120112085353200_ehab819-B8","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1093\/eurheartj\/ehaa671","article-title":"Validation of high bleeding risk criteria and definition as proposed by the Academic Research Consortium for High Bleeding Risk","volume":"41","author":"Corpataux","year":"2020","journal-title":"Eur Heart J"},{"key":"2021120112085353200_ehab819-B9","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehab658","article-title":"The Cornelian dilemma of quitting DAPT","volume":"42","author":"Motovska","year":"2021","journal-title":"Eur Heart J"},{"key":"2021120112085353200_ehab819-B10","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehab680","article-title":"Myocardial revascularization in ischaemic cardiomyopathy: routine practice vs. scientific evidence","author":"De Caterina","year":"2021","journal-title":"Eur Heart J"},{"key":"2021120112085353200_ehab819-B11","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehab509","article-title":"Effects of initial invasive vs. initial conservative treatment strategies on recurrent and total cardiovascular events in the ISCHEMIA trial","author":"Lopez-Sendon","year":"2021","journal-title":"Eur Heart J"},{"key":"2021120112085353200_ehab819-B12","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehab445","article-title":"Is there equivalence between PCI and CABG surgery in long-term survival of patients with diabetes? Importance of interpretation biases and biological plausibility","author":"Boden","year":"2021","journal-title":"Eur Heart J"},{"key":"2021120112085353200_ehab819-B13","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehab246","article-title":"Cardiac mortality in patients randomized to elective coronary revascularisation plus medical therapy or medical therapy alone: a systematic review and meta-analysis","volume":"42","author":"Navarese","year":"2021","journal-title":"Eur Heart J"},{"key":"2021120112085353200_ehab819-B14","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehab330","article-title":"Impact of revascularisation on outcomes in chronic coronary syndromes: a new meta-analysis with the same old biases?","volume":"42","author":"Brown","year":"2021","journal-title":"Eur Heart J"},{"key":"2021120112085353200_ehab819-B15","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1093\/eurheartj\/ehz371","article-title":"High FFR strongly predicts arterial graft dysfunction: pure benefit in a pure population?","volume":"40","author":"Kern","year":"2019","journal-title":"Eur Heart J"},{"key":"2021120112085353200_ehab819-B16","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehab449","article-title":"Post-stenting fractional flow reserve vs. coronary angiography for optimization of percutaneous coronary intervention: TARGET-FFR trial","volume":"42","author":"Collison","year":"2021","journal-title":"Eur Heart J"},{"key":"2021120112085353200_ehab819-B17","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehab525","article-title":"We need intracoronary physiology guidance before percutaneous coronary intervention, but do we need it post-stenting?","volume":"42","author":"Erlinge","year":"2021","journal-title":"Eur Heart J"},{"key":"2021120112085353200_ehab819-B18","doi-asserted-by":"crossref","first-page":"3853","DOI":"10.1093\/eurheartj\/ehab538","article-title":"Coronary CT angiography as an \u2018one-stop shop\u2019 to detect the high-risk plaque and the vulnerable patient","volume":"42","author":"Antoniades","year":"2021","journal-title":"Eur Heart J"},{"key":"2021120112085353200_ehab819-B19","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1093\/eurheartj\/ehaa227","article-title":"Vulnerable plaques and patients: state-of-the-art","volume":"41","author":"Tomaniak","year":"2020","journal-title":"Eur Heart J"},{"key":"2021120112085353200_ehab819-B20","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1093\/eurheartj\/ehz678","article-title":"Pursuit for the detection of vulnerable plaque","volume":"41","author":"Jang","year":"2020","journal-title":"Eur Heart J"},{"key":"2021120112085353200_ehab819-B21","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehab433","article-title":"Thin-cap fibroatheroma predicts clinical events in diabetic\u2002patients with normal fractional flow reserve: the COMBINE OCT-FFR trial","volume":"42","author":"Kedhi","year":"2021","journal-title":"Eur Heart J"},{"key":"2021120112085353200_ehab819-B22","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehab521","article-title":"What are the PROSPECTs and clinical implications of vulnerable plaque?","volume":"42","author":"Al-Lamee","year":"2021","journal-title":"Eur Heart J"},{"key":"2021120112085353200_ehab819-B23","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehab607","article-title":"Ticagrelor monotherapy in CKD: better safety at what price?","volume":"42","author":"Parker","year":"2021","journal-title":"Eur Heart J"},{"key":"2021120112085353200_ehab819-B24","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehab676","article-title":"Cardiac death should be the primary endpoint for revascularization trials and meta-analyses","volume":"42","author":"White","year":"2021","journal-title":"Eur Heart J"},{"key":"2021120112085353200_ehab819-B25","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehab677","article-title":"Cardiac mortality, adequate power, and objective inclusion of the entire evidence are key to accurately define the long-term effect of revascularization vs. medical therapy alone in stable coronary syndromes","volume":"42","author":"Navarese","year":"2021","journal-title":"Eur Heart J"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/42\/45\/4607\/41426987\/ehab819.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/42\/45\/4607\/41426987\/ehab819.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T21:35:06Z","timestamp":1673904906000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/42\/45\/4607\/6447302"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,1]]},"references-count":25,"journal-issue":{"issue":"45","published-online":{"date-parts":[[2021,12,1]]},"published-print":{"date-parts":[[2021,12,1]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehab819","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"type":"print","value":"0195-668X"},{"type":"electronic","value":"1522-9645"}],"subject":[],"published-other":{"date-parts":[[2021,12,1]]},"published":{"date-parts":[[2021,12,1]]}}}